BNP Paribas Financial Markets’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $113K | Sell |
9,700
-503
| -5% | -$7.18K | ﹤0.01% | 4483 |
|
|
2026
Q1 | $171K | Sell |
10,203
-179
| -2% | -$3.2K | ﹤0.01% | 4120 |
|
|
2025
Q4 | $166K | Sell |
10,382
-69,246
| -87% | -$1.03M | ﹤0.01% | 4139 |
|
|
2025
Q3 | $984K | Buy |
79,628
+75,122
| +1,667% | +$881K | ﹤0.01% | 3150 |
|
|
2025
Q2 | $51.9K | Buy |
4,506
+546
| +14% | +$6.48K | ﹤0.01% | 4246 |
|
|
2025
Q1 | $59.4K | Sell |
3,960
-3,172
| -44% | -$53.1K | ﹤0.01% | 4229 |
|
|
2024
Q4 | $123K | Buy |
+7,132
| New | +$138K | ﹤0.01% | 4082 |
|
|
2023
Q2 | – | Sell |
-1,131
| Closed | -$24.9K | – | 3930 |
|
|
2023
Q1 | $24.9K | Sell |
1,131
-515
| -31% | -$12.1K | ﹤0.01% | 3500 |
|
|
2022
Q4 | $33.4K | Sell |
1,646
-974
| -37% | -$18.9K | ﹤0.01% | 3481 |
|
|
2022
Q3 | $35.3K | Sell |
2,620
-1,760
| -40% | -$29.7K | ﹤0.01% | 4039 |
|
|
2022
Q2 | $86.8K | Sell |
4,380
-5,022
| -53% | -$133K | ﹤0.01% | 3400 |
|
|
2022
Q1 | $297K | Sell |
9,402
-334,890
| -97% | -$9.39M | ﹤0.01% | 2985 |
|
|
2021
Q4 | $7.68M | Buy |
344,292
+25,160
| +8% | +$656K | 0.01% | 1115 |
|
|
2021
Q3 | $8.86M | Buy |
319,132
+186,476
| +141% | +$5.68M | 0.01% | 1004 |
|
|
2021
Q2 | $5.17M | Buy |
132,656
+15,024
| +13% | +$539K | 0.01% | 1266 |
|
|
2021
Q1 | $3.39M | Buy |
117,632
+93,327
| +384% | +$3.19M | 0.01% | 1389 |
|
|
2020
Q4 | $644K | Buy |
24,305
+9,516
| +64% | +$194K | ﹤0.01% | 2324 |
|
|
2020
Q3 | $226K | Sell |
14,789
-20,823
| -58% | -$437K | ﹤0.01% | 2705 |
|
|
2020
Q2 | $724K | Sell |
35,612
-88,558
| -71% | -$1.59M | ﹤0.01% | 1939 |
|
|
2020
Q1 | $1.28M | Buy |
124,170
+75,781
| +157% | +$2.12M | ﹤0.01% | 1751 |
|
|
2019
Q4 | $1.82M | Buy |
48,389
+40,462
| +510% | +$1.82M | ﹤0.01% | 1719 |
|
|
2019
Q3 | $370K | Buy |
7,927
+5,235
| +194% | +$243K | ﹤0.01% | 2369 |
|
|
2019
Q2 | $141K | Sell |
2,692
-35,270
| -93% | -$2.07M | ﹤0.01% | 2829 |
|
|
2019
Q1 | $2.62M | Buy |
37,962
+30,773
| +428% | +$2.06M | 0.01% | 1288 |
|
|
2018
Q4 | $429K | Sell |
7,189
-1,409
| -16% | -$122K | ﹤0.01% | 1856 |
|
|
2018
Q3 | $996K | Buy |
8,598
+1,859
| +28% | +$210K | ﹤0.01% | 1755 |
|
|
2018
Q2 | $851K | Buy |
6,739
+1,411
| +26% | +$172K | ﹤0.01% | 1802 |
|
|
2018
Q1 | $577K | Sell |
5,328
-7,867
| -60% | -$871K | ﹤0.01% | 2115 |
|
|
2017
Q4 | $1.45M | Sell |
13,195
-8,707
| -40% | -$869K | ﹤0.01% | 1702 |
|
|
2017
Q3 | $2.16M | Sell |
21,902
-533
| -2% | -$51.7K | 0.01% | 1099 |
|
|
2017
Q2 | $2.27M | Buy |
22,435
+13,146
| +142% | +$1.42M | 0.01% | 1113 |
|
|
2017
Q1 | $1.07M | Buy |
9,289
+4,314
| +87% | +$501K | ﹤0.01% | 1322 |
|
|
2016
Q4 | $597K | Sell |
4,975
-835
| -14% | -$92.5K | ﹤0.01% | 1593 |
|
|
2016
Q3 | $653K | Buy |
5,810
+490
| +9% | +$56.4K | ﹤0.01% | 1092 |
|
|
2016
Q2 | $659K | Buy |
5,320
+442
| +9% | +$53.4K | ﹤0.01% | 1373 |
|
|
2016
Q1 | $548K | Buy |
4,878
+1,726
| +55% | +$179K | ﹤0.01% | 1181 |
|
|
2015
Q4 | $343K | Sell |
3,152
-24,896
| -89% | -$2.85M | ﹤0.01% | 1230 |
|
|
2015
Q3 | $2.8M | Buy |
28,048
+24,743
| +749% | +$2.69M | 0.01% | 777 |
|
|
2015
Q2 | $377K | Sell |
3,305
-162
| -5% | -$19.6K | ﹤0.01% | 1446 |
|
|
2015
Q1 | $362K | Buy |
3,467
+648
| +23% | +$69K | ﹤0.01% | 1403 |
|
|
2014
Q4 | $339K | Buy |
2,819
+1,020
| +57% | +$134K | ﹤0.01% | 1235 |
|
|
2014
Q3 | $263K | Sell |
1,799
-9,012
| -83% | -$1.39M | ﹤0.01% | 1763 |
|
|
2014
Q2 | $1.81M | Buy |
10,811
+5,652
| +110% | +$1.01M | ﹤0.01% | 989 |
|
|
2014
Q1 | $968K | Sell |
5,159
-3,685
| -42% | -$696K | ﹤0.01% | 1170 |
|
|
2013
Q4 | $1.69M | Buy |
8,844
+3,220
| +57% | +$599K | ﹤0.01% | 908 |
|
|
2013
Q3 | $952K | Sell |
5,624
-190
| -3% | -$29.5K | ﹤0.01% | 1166 |
|
|
2013
Q2 | $882K | Buy |
+5,814
| New | +$824K | ﹤0.01% | 1099 |
|
Other funds holding CLB
AI
DGI
CAMG
BNP Paribas Financial Markets's CLB Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Core Laboratories (CLB) stake by 4.9% in Q2 2026, selling an estimated $7.18K and leaving 9,700 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #4483.
BNP Paribas Financial Markets first reported a position in CLB in Q2 2013 and has held it in 47 quarters since. The position peaked at $8.86M in Q3 2021. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- BNP Paribas Financial Markets held 9,700 shares of Core Laboratories worth $113K as of Q2 2026.
- BNP Paribas Financial Markets sold 503 Core Laboratories shares in Q2 2026, an estimated $7.18K.
- Core Laboratories made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4483 holding.
- BNP Paribas Financial Markets first reported a position in Core Laboratories in Q2 2013 and has held it in 47 quarters since.
- BNP Paribas Financial Markets's Core Laboratories position peaked at $8.86M in Q3 2021.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.